OncoTherapy Science Inc. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,018
770
267
287
211
280,586
SG&A Expense
4,619
2,579
3,064
3,121
3,042
2,735,186
EBIT
3,786
1,962
2,981
3,004
2,989
2,953,776
Unusual Expense
50
578
174
11
58
235,624
Non Operating Income/Expense
17
6
11
6
10
6,188
Pretax Income
3,716
1,362
2,789
2,998
2,919
3,194,655
Income Tax
95
44
1
4
7
2,841
Consolidated Net Income
3,621
1,318
2,789
3,002
2,926
3,191,814
Net Income
3,677
1,335
2,789
3,002
2,851
2,934,961
Net Income After Extraordinaries
3,677
1,335
2,789
3,002
2,851
2,934,961
Net Income Available to Common
3,677
1,335
2,789
3,002
2,851
2,934,960
EPS (Basic)
28.20
9.09
18.97
20.42
19.39
19.90
Basic Shares Outstanding
130
147
147
147
147
147,501.70
EPS (Diluted)
28.20
9.09
18.97
20.42
19.39
19.90
Diluted Shares Outstanding
130
147
147
147
147
147,501.70
EBITDA
3,686
1,856
2,855
2,915
2,840
2,561,778
Other Operating Expense
85
47
58
80
9
107,178
Non-Operating Interest Income
3
17
7
2
1
931
Minority Interest Expense
56
17
-
-
75
256,853
About OncoTherapy Science
View Profile
